BioCentury | Apr 15, 2013
Company News

Integra LifeSciences Corp. management update

...Hired: Gretchen Johnson as VP of market development, formerly general manager for burn products at Genzyme Tissue Repair WIR...
BioCentury | Sep 4, 2008
Tools & Techniques

Smooth Grafts Ahead

Researchers at the Georgia Institute of Technology have developed an approach to address a major problem with synthetic tissue grafts: poor integration with host tissue. The group used polymer-immobilized retroviruses to control cell differentiation and...
BioCentury | Jul 16, 2007
Product Development

Discontinued agents

...agents Company Product Reason for discontinuation Genzyme Vianain ananain debriding enzyme In 1995, the company's Genzyme Tissue Repair...
...discontinued. (A) Genzyme/Celtrix (acquired by Insmed in 2000) Recombinant transforming growth factor (TGF) beta 2 Genzyme Tissue Repair...
BioCentury | May 12, 2003
Finance

Family values

...from the first quarter of 2002. Synvisc was developed by Biomatrix , which merged with Genzyme Tissue Repair...
BioCentury | Mar 19, 2001
Clinical News

NeuroCell-PD: Phase II

...the start of that clinical study. The milestone falls under a 1999 agreement in which Genzyme Tissue Repair...
BioCentury | Mar 16, 2001
Top Story

NeuroCell-PD fails in Phase II

...the start of that clinical study. The milestone falls under a 1999 agreement in which Genzyme Tissue Repair...
BioCentury | Jan 8, 2001
Company News

Antigenics management update

...York, N.Y. Business: Autoimmune/Inflammation, Cancer, Infectious diseases Hired: Russell Herndon as COO, formerly president of Genzyme Tissue Repair WIR...
BioCentury | Oct 2, 2000
Tools & Techniques

Genzyme, CAT and TGF-beta

...wound healing (see BioCentury, Feb. 13, 1995 & May 26, 1998). However, GENZ's sister company Genzyme Tissue Repair...
BioCentury | Sep 18, 2000
Clinical News

NeuroCell-PD: Phase II trial enrollment

...In 1999, Genzyme Tissue Repair (GZTR, Cambridge, Mass.) transferred to GENZ its 50 percent interest in a NeuroCell...
BioCentury | Sep 5, 2000
Company News

Biomatrix, Genzyme deal

...additional time to complete the formation of Genzyme Biosurgery (see BioCentury, March 13). In March, Genzyme Tissue Repair...
Items per page:
1 - 10 of 99
BioCentury | Apr 15, 2013
Company News

Integra LifeSciences Corp. management update

...Hired: Gretchen Johnson as VP of market development, formerly general manager for burn products at Genzyme Tissue Repair WIR...
BioCentury | Sep 4, 2008
Tools & Techniques

Smooth Grafts Ahead

Researchers at the Georgia Institute of Technology have developed an approach to address a major problem with synthetic tissue grafts: poor integration with host tissue. The group used polymer-immobilized retroviruses to control cell differentiation and...
BioCentury | Jul 16, 2007
Product Development

Discontinued agents

...agents Company Product Reason for discontinuation Genzyme Vianain ananain debriding enzyme In 1995, the company's Genzyme Tissue Repair...
...discontinued. (A) Genzyme/Celtrix (acquired by Insmed in 2000) Recombinant transforming growth factor (TGF) beta 2 Genzyme Tissue Repair...
BioCentury | May 12, 2003
Finance

Family values

...from the first quarter of 2002. Synvisc was developed by Biomatrix , which merged with Genzyme Tissue Repair...
BioCentury | Mar 19, 2001
Clinical News

NeuroCell-PD: Phase II

...the start of that clinical study. The milestone falls under a 1999 agreement in which Genzyme Tissue Repair...
BioCentury | Mar 16, 2001
Top Story

NeuroCell-PD fails in Phase II

...the start of that clinical study. The milestone falls under a 1999 agreement in which Genzyme Tissue Repair...
BioCentury | Jan 8, 2001
Company News

Antigenics management update

...York, N.Y. Business: Autoimmune/Inflammation, Cancer, Infectious diseases Hired: Russell Herndon as COO, formerly president of Genzyme Tissue Repair WIR...
BioCentury | Oct 2, 2000
Tools & Techniques

Genzyme, CAT and TGF-beta

...wound healing (see BioCentury, Feb. 13, 1995 & May 26, 1998). However, GENZ's sister company Genzyme Tissue Repair...
BioCentury | Sep 18, 2000
Clinical News

NeuroCell-PD: Phase II trial enrollment

...In 1999, Genzyme Tissue Repair (GZTR, Cambridge, Mass.) transferred to GENZ its 50 percent interest in a NeuroCell...
BioCentury | Sep 5, 2000
Company News

Biomatrix, Genzyme deal

...additional time to complete the formation of Genzyme Biosurgery (see BioCentury, March 13). In March, Genzyme Tissue Repair...
Items per page:
1 - 10 of 99